RSV usually only has mild symptoms, but it can lead to breathing problems in the most vulnerable infants. The vaccine is ...

Palivizumab injection (Synagis), an RSV prevention therapy for children, is being discontinued and will no longer be available as of December 31, 2025.

In babies, RSV is a common cause of a type of chest infection called bronchiolitis. Last week, the UK Health Security Agency ...

Pfizer Inc (($PFE)) announced an update on their ongoing clinical study. Pfizer Inc. is conducting a study titled Retrospective Study Evaluating ...

RSV hospitalization was associated with increased risk for new CVEs and worsening of preexisting cardiovascular conditions.

Expectant parents could soon have another new option this fall to protect their newborns from RSV, or respiratory syncytial virus, the most common cause of hospitalization in American infants ...

With COVID-19 hospitalizations rising and flu and RSV on the horizon, experts say it’s time to boost up your immunity ahead of the fall and winter season. Here are answers to some frequently ...

Among adults 65 and older, about 177,000 are hospitalized with RSV and 14,000 die annually. Worldwide, RSV kills about 100,000 children a year, mostly in poor countries. Why is there no vaccine?

RSV seasons can vary in timing in different parts of the U.S., the CDC says, so it’s ultimately up to local, state and territorial health departments to determine the best time to start and stop ...

RSV infections of the lungs and airways send up to 160,000 older adults to the hospital each year, at an annual cost of more than $1.3 billion, according to the Michigan Medicine report.

No RSV vaccine has been approved by the Food and Drug Administration, but the first attempt was made in the 1960s, which was unsuccessful as it led to severe and lethal cases of lung inflammatory ...

An RSV surge across the country has taken parents' and health workers by surprise. The number of new cases is up 300% compared to a typical season in some places.